A new quantitative in vitro microculture method for Giardia duodenalis trophozoites

被引:44
作者
Benere, Ely
Inocencio da Luz, Raquel Andreia
Vermeersch, Marieke
Cos, Paul
Maes, Louis
机构
[1] Univ Antwerp, Fac Pharamceut Biomed & Vet Sci, LMPH, B-2020 Antwerp, Belgium
[2] Inst Trop Med, B-2000 Antwerp, Belgium
关键词
giardia duodenalis; trophozoites; in vitro microculture; resazurin; drug susceptibility assay;
D O I
10.1016/j.mimet.2007.07.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A reliable, rapid and low-cost method for drug sensitivity determination of Giardia duodenalis trophozoites (WB-strain) was developed in a 96-well plate. Using a standard moculum of 5 x 10(4) trophozoites per well (300 mu l), good growth was obtained after sealing the plate with an airtight adhesive tape and incubation at 37 degrees C for 72 h in modified TYI-S-33 medium. Viable burdens were quantified using the formazan dyes NITT (100 mu g/well) and XTT (20 mu g/well) and the fluorescent substrate resazurin (2.5 mu g/well). Prior removal of the culture medium is required since it causes spontaneous reduction of the substrate. Resazurin proved to be far superior to NITT and XTT with a level of sensitivity of about 3 x 104 trophozoites. Inhibitory concentrations (IC50) of several anti-giardial reference drugs were within the range of published values: metronidazole 2.25 mu M, tinidazole 1.75 mu M, albendazole 0.10 mu M, furazolidone 2.00 mu M and quirracrine 0.32 mu M. The broad-spectrum antibiotics chloramphenicol, rifampicin, penicillin G+streptomycin and gentamycin were devoid of any inhibitory activity and are considered suitable for decontamination during excystation experiments. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 24 条
[21]   Drug susceptibility testing of anaerobic protozoa [J].
Upcroft, JA ;
Upcroft, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1810-1814
[22]  
VISTICA DT, 1991, CANCER RES, V51, P2515
[23]  
WRIGHT CW, 1992, T ROY SOC TROP MED H, V86, P517, DOI 10.1016/0035-9203(92)90127-X
[24]  
Wright Janelle M, 2003, Expert Opin Drug Saf, V2, P529, DOI 10.1517/14740338.2.6.529